Evidence map›Paper›PMID 38234901›Full record

ArticleHeliyon2024

One-pot synthesis optimization of thiol-capped SnS and SnS/ZnS QDs for photocatalytic degradation of Rhodamine 6G.

Madillo Mareka, Mangaka Matoetoe, Ncediwe Tsolekile

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Madillo MarekaChemistry Department, Cape Peninsula University of Technology, PO Box 1906, Bellville, 7535, South Africa.
Mangaka MatoetoeChemistry Department, Cape Peninsula University of Technology, PO Box 1906, Bellville, 7535, South Africa.
Ncediwe TsolekileChemistry Department, Cape Peninsula University of Technology, PO Box 1906, Bellville, 7535, South Africa.
Cape Peninsula University of Technology · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interest in SnS-based quantum dots (QDs) has increased due to their low toxicity, widespread natural availability, and superior electro-optical characteristics suitable for photodegradation applications. Herein, we report the synthesis of SnS-based QDs using thiourea and tin (II)chloride as salt precursors. The study explored the impact of various synthetic parameters such as pH, capping ligand, Sn:S ratio, reaction solvent, and ZnS shell on the optical characteristics of the synthesized QDs. The optimal QDs properties were observed at pH = 3 and Sn:S ratio = 1:1. Transmission electron microscopy analysis showed spherical nanoparticles, while the Fourier Transform Infrared spectroscopy revealed QDs with thiol capping. Time-dependent studies revealed that when the QDs were synthesized using propylene glycol, the ultraviolet-visibile (UV-vis) spectrum exhibited an increase in absorbance over time and improved stability compared to aqueous synthesized QDs. SnS/ZnS QDs capped with 3-mercaptopropanoic acid exhibited improved photoluminscence (PL) emissions, stability, and aqueous dispersion compared to glutathione and l-Cysteine as thiol-capping agents. The photocatalytic activity of SnS/ZnS QDs was assessed against Rhodamine 6G and increased to 65 % when passivated with ZnS compared to 31 % for the core SnS QDs. With the given findings, this study supports the stability and effectiveness of the SnS/ZnS QDs as a viable dye degradant.

Indexed as

Dye degradationQuantum dotsRhodamine 6GSnSSnS/ZnSThiol capping

Identifiers

PMID38234901
PMCPMC10792565
OpenAlexW4390603791

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.